Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-02

Clinical Trial Update: Buprenorphine in the Emergency Department [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating buprenorphine in the emergency department for opioid withdrawal and opioid-use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: St. Joseph's Health Centre Toronto | Conditions: Opioid Withdrawal, Opioid-use Disorder | Phase 4 | Status: COMPLETED